Euclidean Capital’s Surrozen SRZN Stock Holding History

Euclidean Capital’s Portfolio SRZN Stock Details SRZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.28M	Hold	87,696	–	–	0.52%	9
2026 Q1	$2.55M	Hold	87,696	–	–	0.65%	8
2025 Q4	$1.98M	Hold	87,696	–	–	0.54%	10
2025 Q3	$1.13M	Hold	87,696	–	–	0.47%	10
2025 Q2	$784K	Hold	87,696	–	–	0.26%	8
2025 Q1	$1.02M	Hold	87,696	–	–	0.38%	8
2024 Q4	$1.26M	Hold	87,696	–	–	0.17%	9
2024 Q3	$1.05M	Hold	87,696	–	–	0.12%	11
2024 Q2	$960K	Hold	87,696	–	–	0.12%	10
2024 Q1	$1.38M	Hold	87,696	–	–	0.18%	12
2023 Q4	$824K	Sell	87,696 -2	-0%	-$14	0.09%	12
2023 Q3	$645K	Buy	87,698 +34,167	+64%	+$325K	0.14%	12
2023 Q2	$442K	Hold	53,531	–	–	0.11%	12
2023 Q1	$483K	Hold	53,531	–	–	0.42%	10
2022 Q4	$467K	Hold	53,531	–	–	0.44%	11
2022 Q3	$1.62M	Hold	53,531	–	–	1.51%	10
2022 Q2	$2.41M	Hold	53,531	–	–	2.05%	10
2022 Q1	$2.42M	Hold	53,531	–	–	1.4%	11
2021 Q4	$5.17M	Hold	53,531	–	–	2.94%	8
2021 Q3	$5.68M	Buy	+53,531	New	+$7.53M	2.76%	8

Other funds holding SRZN

Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Euclidean Capital's SRZN Position: Q2 2026 in Review

Euclidean Capital held its Surrozen (SRZN) position steady in Q2 2026 at 87,696 shares worth $2.28M. The position accounts for 0.52% of the portfolio, ranked #9.

Euclidean Capital first reported a position in SRZN in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.68M in Q3 2021. 70 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.

Euclidean Capital held 87,696 shares of Surrozen worth $2.28M as of Q2 2026.
Euclidean Capital left its Surrozen share count unchanged in Q2 2026.
Surrozen made up 0.52% of Euclidean Capital's portfolio in Q2 2026, its #9 holding.
Euclidean Capital first reported a position in Surrozen in Q3 2021 and has held it in 20 quarters since.
Euclidean Capital's Surrozen position peaked at $5.68M in Q3 2021.
70 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.

Based on Euclidean Capital's 13F filing for Q2 2026, filed 14 Aug 2026.